Atlanta-based Surterra Holdings filed a Form D with the SEC on December 9th indicating it had raised $10.3mm from the sale of equity to 3 investors, with the first sale having taken place November 8th. According to the Atlanta Business Chronicle, which checked with CFO Jim Whitcomb, Surterra has raised $15mm.
Surterra holds one of the six licenses in Florida’s low-THC medical cannabis program and is headed by CEO Jake Bergmann, a 2009 graduate of Georgia State University who also heads hedge fund Valkyrie Capital, which he founded in 2012. Other officers and directors mentioned in the filing include Wesley Van Dyk, also an employee of Valkyrie Capital, James Whitcomb, Jason Becker, Tom Venables, John Rasmussen and Cameron Champion. Surterra currently operates a single dispensary in Tampa and cultivates and processes in Tallahassee.
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email
